Researchers found 1,639 of 7,508 medicine samples in Africa failed quality tests, being substandard or falsified, raising concerns of failed treatments and preventable deaths.
UN estimates suggest up to 500,000 deaths annually in sub-Saharan Africa due to substandard or fake medicines, with significant impacts on public health and treatment effectiveness.
The WHO highlighted the prevalence of falsified antibiotics and antimalarials in Africa, emphasizing the risks of incorrect dosages, ineffective treatments, and antimicrobial resistance.
Malawi was identified with the highest proportion of substandard and falsified medicines, indicating complex supply chain issues and challenges in accessing essential medicines across many low- and middle-income countries.
Collection
[
|
...
]